Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62
6 suppliers awarded•15 lots awarded•€1.38M awarded
Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland
Awarded value
€1.38M
Estimated value
€1.38M
Awarded at 100% of estimated value
Award date
May 31, 2026
Winners
6
Lots awarded
15
Award values
Notice total
€1.38M
Sum of lot awards
€1.39M
TED notice total and lot-level values do not exactly match.
Winners
Wrocław, POL
€578,162 This contract
60 award notices•213 awarded lots•€218.51M total
WARSZAWA, POL
€465,693 This contract
12 award notices•25 awarded lots•€13.13M total
Warszawa, POL
€82,686 This contract
7 award notices•13 awarded lots•€4.17M total
Warszawa, POL
€48,783 This contract
8 award notices•12 awarded lots•€229,598 total
WARSZAWA, POL
€18,221 This contract
11 award notices•13 awarded lots•€1.68M total
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Abbvie sp. z o.o. | €446,616 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | Urtica sp. z o.o. | €254,070 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | Urtica sp. z o.o. | €225,737 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | Not specified | €165,606 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0006 | Urtica sp. z o.o. | €55,358 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | InPharm Sp. z o.o. | €51,361 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | Centrala Farmaceutyczna Cefarm SA | €48,783 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0012 | Asclepios S.A. | €29,400 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0002 | Abbvie sp. z o.o. | €19,077 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | Amgen Sp. z o.o. | €18,221 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | InPharm Sp. z o.o. | €18,221 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | Urtica sp. z o.o. | €17,000 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0014 | Urtica sp. z o.o. | €16,309 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | InPharm Sp. z o.o. | €13,104 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0013 | Urtica sp. z o.o. | €9,688 | Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000) |